Coltene Holding (CLTN.SW) Osake Kurssi
Coltene Holding Kurssi
Coltene Holdingn liikevaihto on supistunut 0,2 % vuodessa viimeisten 19 vuoden aikana 240,05 M CHF:een. Osakekohtainen tulos on laskenut 3,5 % vuodessa viimeisten 19 vuoden aikana. Coltene Holdingn nettomarginaali on nyt 6,2 %, laskenut 11,4 %:sta muutama vuosi sitten. Coltene Holdingn osinkotuotto on tällä hetkellä noin 5,10 %. Jakosuhde on noin 100 % tuloksesta. Osinko on kasvanut 2,5 % vuodessa viimeisten 18 vuoden aikana. Analyytikoiden mediaanitavoitehinta on 58,14 CHF, eli yli nykyhintaa 18,7 %. 8 analyytikosta 6 suosittaa ostoa — kokonaiskonsensus on Osta.
Coltene Holding osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Coltene Holding liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Coltene Holding -osakkeesta
The business model of Coltene Holding AG is focused on developing, manufacturing, and marketing dental consumables and small equipment for dentists and dental technicians. Coltene offers a wide range of products including dental restorative materials, endodontic instruments, dental cements, and prosthetic materials. They also provide treatment concepts, software solutions, and other services to support dental professionals in their practices. With a commitment to innovation, quality, and customer satisfaction, Coltene aims to continually enhance and expand their product portfolio to meet the evolving needs of the dental industry. Coltene Holding AG is a leading global provider of dental solutions.
Coltene Holding AG is primarily active in the dental industry.
Coltene Holding AG faces competition from various companies in the market. Some of the main competitors of Coltene Holding AG include Dentsply Sirona, Straumann Holding AG, 3M Company, Ivoclar Vivadent AG, and Zimmer Biomet Holdings, Inc. These companies also operate in the dental industry, providing products and services similar to Coltene Holding AG. While Coltene Holding AG strives to differentiate itself through innovative solutions and high-quality dental materials, it continuously monitors and adapts to the competitive landscape to maintain its position in the market.
Coltene Holding AG is a renowned dental company with a rich history and background. Founded in 1959, Coltene has continually evolved and expanded its product offering in the dental industry. With headquarters in Switzerland, it has become a global leader in the development, manufacturing, and sale of dental consumables and equipment. Coltene is dedicated to providing innovative solutions to dental professionals, including dental materials, restoration instruments, endodontic products, and digital dentistry solutions. Their commitment to quality, customer satisfaction, and technological advancements has enabled Coltene to establish a strong presence worldwide in the dental market.
Coltene Holding AG, a prominent stock, has achieved several significant milestones. One was the successful launch of the groundbreaking ParaPost® Fiber Lux in 2009, enhancing its dental product portfolio. Another milestone was in 2011, when Coltene acquired MicroMega, a leading French manufacturer of endodontics products, expanding its market presence. Moreover, in 2013, Coltene developed the breakthrough HyFlex™ CM rotary file system, revolutionizing endodontic treatment. This company has consistently demonstrated its commitment to innovation and growth, solidifying its position as an industry leader. With these achievements, Coltene Holding AG continues to pave the way for advancements in the dental field.
Coltene Holding AG is primarily present in various countries and regions around the world. With its global reach, the company has established a strong presence in Europe, North America, Asia-Pacific, and the Middle East. Coltene Holding AG serves its customers and partners in countries such as Switzerland, Germany, the United States, China, India, Japan, and the United Arab Emirates, among others. This global presence allows Coltene Holding AG to effectively cater to the dental and healthcare industry on an international scale, delivering its high-quality products and services to diverse markets worldwide.
Coltene Holding AG represents values of quality, innovation, and patient care. With a strong corporate philosophy, Coltene is committed to delivering dental solutions that enhance oral health worldwide. The company focuses on continuously developing technologically advanced products and solutions that meet the highest industry standards. Coltene Holding AG prioritizes customer satisfaction by providing reliable, precise, and efficient dental materials and equipment. By incorporating cutting-edge research, development, and manufacturing processes, Coltene ensures exceptional quality and long-lasting dental solutions. With a dedication to excellence, Coltene Holding AG aims to improve dental professionals' workflow and ultimately enhance patient experience in the dental industry.
Analyytikot asettavat tällä hetkellä Coltene Holding-osakkeelle keskimääräisen tavoitehinnan 58,14 CHF (mediaani: 58,14 CHF), mikä merkitsee +17,9 % viimeisimpään hintaan verrattuna. Konsensus perustuu 8 analyytikkoarvioon.
8 analyytikkoa arvioi tällä hetkellä Coltene Holding-osaketta: 6 suosittaa ostoa, 2 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Coltene Holding-yhtiöltä 239,00 M CHF liikevaihtoa ja 1,90 CHF osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Coltene Holding-osake noteerataan hintaan 53,40 EUR (49,00 CHF).
Coltene Holding-osake (CLTN.SW) on listattuna 4 pörssissä, muun muassa: London (0QP7.L), SIX (Zürich) (CLTN.SW), Frankfurt (M3Z.F).
The Coltene Holding AG is an internationally active company specializing in the development, manufacturing, and distribution of dental products. Based in Altstätten, Switzerland, the company has been operating for over 60 years in more than 90 countries worldwide, making it one of the leading providers in this field. Coltene's business model includes various divisions and products. One of Coltene's core divisions is the production of materials for dentistry. The company offers a wide range of high-quality, precise, and safe materials for dental prophylaxis and restorative treatment. These include adhesives, composites, bonding materials, impression materials, as well as sealing and filling materials. The products of the brands BRILLIANT Crios, COLTENE, and DMG are particularly well-known. Another important component of Coltene's business model is the development and manufacturing of instruments and devices for dental practices. These include root canal instruments, rotary instruments, files, scalers, impression trays, mouth mirrors, as well as turbines and motors. Here too, the focus is on the highest quality, precision, and efficiency. Coltene also focuses on innovation in the field of digitization. For example, the company produces digital impression and planning systems such as CEREC, CEREC Omnicam, and iTero. These systems enable the precise capture of dental structures and greatly facilitate the work of dentists. In the division of dental hygiene and prophylaxis, Coltene offers numerous products for cleaning and caring for teeth and the oral cavity. These include toothbrushes, interdental brushes, dental floss, mouthwashes, and many other products that contribute to improving oral hygiene and preventing diseases such as cavities or periodontitis. Another component of Coltene's business model is the area of research and development. The company works closely with universities and research institutions to develop innovative products and solutions for dentistry. The focus is particularly on the use of state-of-the-art technologies and materials, as well as the continuous optimization of products. In summary, Coltene's business model is based on a broad range of products in the field of dentistry. The company offers high-quality materials, instruments, and devices, as well as innovative digital solutions and products for oral hygiene and prophylaxis. Coltene always prioritizes the highest quality, precision, and efficiency, also in the areas of research and development.
odotettu liikevaihto Coltene Holding on 239,00 M CHF. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Coltene Holding on 11,36 M CHF. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Coltene Holding:n hinta-voitto-suhde (P/E) on tällä hetkellä 25,77. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Coltene Holding-osakkeen arvostusta.
Coltene Holding:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,23. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Coltene Holding-osakkeen arvostuskennuslukuna.
Coltene Holding:n Eulpool-laatuscore on 3/10.
Coltene Holding:n ISIN on CH0025343259. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Coltene Holding:n WKN on A0J3ED. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Coltene Holding:n ticker on CLTN.SW. Tämä pörssinoteeraus käytetään Coltene Holding-osakkeiden kauppaan pörssissä.
Coltene Holding osake
Coltene Holding vertaisryhmä
Coltene Holding Ticker
Coltene Holding FIGI
Kaikki tunnusluvut ja syvällinen analyysi Coltene Holding:sta
Meidän osakeanalyysimme Coltene Holding-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Coltene Holding:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: